Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 AlteredExpression disease BEFREE In vivo, the reduction of lnc-HC expression significantly decreases miR-130b-3p expression, induces PPARγ expression, and increases TG concentration in rat livers with hyperlipidemia. 31770672 2019
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 Biomarker disease BEFREE In HL-SI, GIN decreases MDA-apoA-I and MPO, increases ApoA-I, PON1, and ABCA1, and restores cholesterol efflux disturbed by HL (SIRT1-LXRα/β-PPARγ-ABCG8). 31295384 2019
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 Biomarker disease BEFREE In the liver, aging and comorbidities such as hyperlipidemia and diabetes significantly influence a wide variety of steatosis, but the underlying mechanisms are complex and remain elusive.To establish the modulatory role of FoxO1 and the functional consequences of its altered interaction with PPARγ in the present study, we utilized a cell culture system, aged rats and diabetic db/db mice.We found that, under ER stress, FoxO1 induces PPARγ-mediated lipid accumulation in aged rat livers. 31246177 2019
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 GeneticVariation disease BEFREE The aim of this study was to investigate the individual or combined effects of PPARA-L162V, PPARG-C161T and APOE polymorphisms on hyperlipidemia in coronary heart disease (CHD) patients. 23583468 2013
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 GeneticVariation disease BEFREE In this Chinese cohort, the Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma was not associated with obstructive sleep apnoea hypopnoea syndrome, but was associated with increased hyperlipidaemia risk. 21669017 2011
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 Biomarker disease BEFREE Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia. 21725906 2011
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 Biomarker disease BEFREE PPARalpha and PPARgamma agonists are already in clinical use for the treatment of hyperlipidemia and type 2 diabetes, respectively. 20026355 2010
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 Biomarker disease BEFREE Importantly, synthetic PPARalpha and PPARgamma ligands are currently used for treating hyperlipidemia and diabetes. 19866471 2010
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 Biomarker disease BEFREE Peroxisome proliferator-activated receptor gamma (PPARgamma) agonists and PPARgamma/alpha dual agonists have been or are being developed for clinical use in the treatment of type 2 diabetes mellitus and hyperlipidemias. 19285096 2009
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 AlteredExpression disease LHGDN We propose that HL, exhibited as a high free fatty acid level, modulates GLUT4 gene expression in cardiac muscle via a complex mechanism that includes: (a) binding of AA mediator proteins to three newly identified response elements on the GLUT4 promoter gene and (b) repression of GLUT4 and the PPARgamma genes by AA. 16096283 2005
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.100 AlteredExpression disease BEFREE We propose that HL, exhibited as a high free fatty acid level, modulates GLUT4 gene expression in cardiac muscle via a complex mechanism that includes: (a) binding of AA mediator proteins to three newly identified response elements on the GLUT4 promoter gene and (b) repression of GLUT4 and the PPARgamma genes by AA. 16096283 2005